A study published in the New England Journal of Medicine reports strong results from a clinical trial testing the efficacy of a malaria vaccine. The double-blind, randomized trial found a significant impact on malaria incidence among the group receiving the malaria vaccine.
The full study is available here.
The summary results:
- 894 children were randomly assigned to receive the either the malaria vaccine or hte control vaccine.
- Among the children who completed the study according to the protocol, 32 of 402 (8%) who received the malaria vaccine developed clinical malaria and 66 of 407 (16%) in the control group did.
- Results were similar when all 894 children were included in the intention-to-treat analysis.
- Results were similar in both the trial locations (Tanzania and Kenya).
(h/t Chris Blattman)